Identifying the risks associated with tissue expander infections among patients undergoing mastectomy following clinic-based expansion procedures

Case control analysis of breast tissue expander (TE) infections after clinic-based expansion procedures from 2019 to 2022 in a large county hospital found no significant modifiable risk factors, including implant type. Suboptimal sterile access may be an independent contributor to TE infections following clinic procedures. Ongoing protocol adherence and monitoring are needed.